Kolon ENP (KRX:138490)

CTI BioPharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	242,820	200,260	297,540	332,120	494,000	170,620
Market Cap Growth	-23.62%	-32.70%	-10.41%	-32.77%	189.53%	0.22%
Enterprise Value	171,212	150,894	282,155	356,550	528,075	233,580
Last Close Price	6390.00	5270.00	7549.35	8251.41	12029.42	4108.61
PE Ratio	5.78	5.07	9.07	9.31	22.73	57.00
Forward PE	6.80	6.52	10.24	8.46	4.88	4.88
PS Ratio	0.50	0.41	0.65	0.64	1.22	0.58
PB Ratio	0.74	0.62	1.06	1.30	2.24	0.86
P/TBV Ratio	0.75	0.62	1.07	1.31	2.27	0.87
P/FCF Ratio	6.46	6.05	7.07	11.52	38.91	4.57
P/OCF Ratio	5.14	4.76	6.39	10.39	32.89	4.28
EV/Sales Ratio	0.35	0.31	0.62	0.69	1.30	0.79
EV/EBITDA Ratio	2.98	2.86	5.83	5.87	12.52	12.95
EV/EBIT Ratio	3.82	3.79	8.34	7.74	19.08	61.03
EV/FCF Ratio	4.56	4.56	6.70	12.37	41.59	6.26
Debt / Equity Ratio	0.02	0.03	0.03	0.17	0.25	0.30
Debt / EBITDA Ratio	0.14	0.15	0.20	0.71	1.28	3.27
Debt / FCF Ratio	0.21	0.24	0.23	1.50	4.26	1.58
Asset Turnover	1.23	1.25	1.22	1.37	1.18	0.90
Inventory Turnover	4.45	4.42	3.83	4.01	4.35	4.43
Quick Ratio	1.70	1.73	1.27	0.72	0.58	0.78
Current Ratio	2.81	2.89	2.60	1.63	1.45	1.55
Return on Equity (ROE)	13.68%	13.04%	12.22%	14.99%	10.39%	1.50%
Return on Assets (ROA)	6.63%	6.41%	5.63%	7.61%	5.04%	0.73%
Return on Capital (ROIC)	8.34%	7.97%	7.16%	10.04%	6.51%	0.88%
Return on Capital Employed (ROCE)	12.50%	11.90%	11.50%	17.30%	11.00%	1.50%
Earnings Yield	17.29%	19.71%	11.03%	10.74%	4.40%	1.75%
FCF Yield	15.48%	16.52%	14.14%	8.68%	2.57%	21.89%
Dividend Yield	3.13%	3.79%	2.12%	2.18%	1.21%	-
Payout Ratio	14.48%	15.40%	20.85%	15.45%	-	88.86%
Total Shareholder Return	3.01%	3.79%	2.12%	2.18%	1.21%	-

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.